Xiamen Amoytop Biotech Co.,Ltd.’s Net Profit Rose 85.4% in First Half of 2022

Xiamen Amoytop Biotech Co.,Ltd. (厦门特宝生物工程股份有限公司) (688278.SH) reported a net profit of 133.7 million yuan in the first half of 2022, up 85.4% year-on-year.

Meanwhile, the company posted 714.9 million yuan in revenue, up 52.3% year-on-year.

At the end of the reporting period, it had 1.5 billion yuan in total assets and 280.1 million yuan in total liabilities, with a liability-to-asset ratio of 18.3%.